News

Guyana is moving ahead with revamping its pharmaceutical regulatory system with assistance from Rwanda, as part of ...
Abstract: Recently, the efforts of various public and private Egyptian pharmaceutical companies to adopt green human resources management practices have increased to keep pace with the rapid and ...
TAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company ...
Our holiday schedule is crafted by Human Resources with valuable input from the campus community. During these holidays, KSU will be closed for regular business operations, although some minimal staff ...
Abstract: Proactive human-robot collaborative (HRC) assembly has caught great attention as emerging paradigm for flexible mass personalization in manufacturing with respect to Industry 5.0. To realize ...
As a member of Umpqua Bank's executive leadership team, Giem will oversee the bank's full human resource function, including talent recruiting and retention, professional development, compensation ...
Without a solid, empirical understanding of the key determinants of success, companies may approach this crucial moment blindly, wasting resources and missing ... simulated pre-launch models. As the ...
The pharmaceutical industry is tasked with safeguarding human health by providing life-saving medicines and vaccines, meaning that green and sustainable chemistry approaches have many synergies ...
May 13, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical ... “We are very encouraged by these first-in-human safety and pharmacokinetic data and how they ...
The move could pressure pharmaceutical companies to seek higher revenues in markets like India, potentially impacting its pharmaceutical policies. In recent order announced by the US President Donald ...
on June 15, 2018. President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the pharmaceutical industry before he’s even signed an ...
The pharmaceutical industry is expected to resist, citing potential impacts on research and profits, with legal challenges anticipated. The order's implementation and interaction with the ...